Christian Djurhuus and Nicholas Alp join moderator Bob DiLuzio in an Xtalks session on keeping people engaged with obesity care over time.
Recap by typeshit. Post by Xtalks Webinars on X.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
Reuters reports on GLP-1 users turning to repair shops as their bodies change. Tap through for the full story on where the drugs are reaching everyday businesses.
STAT
Some telehealth companies now market branded and compounded GLP-1s for alcohol use disorder. Experts quoted by STAT worry about fragmented care for an unproven use.
Loading…